Oct. 4 at 1:42 PM
$IRTC $ATYR $WCN $PEBO $CCJ
TOP 5 ANALYST INITIATIONS:
-- Goldman Sachs initiated coverage of iRhythm Technologies (IRTC) with a Neutral rating and
$78 price target. The firm is constructive on the long-term continuous monitoring market but sees potential risk to consensus estimates for iRhythm.
-- Wells Fargo initiated coverage of aTyr Pharma (ATYR) with an Overweight rating and
$17 price target. The analyst believes efzofitimod's odds of success in its Phase 3 sarcoidosis trial are much higher than investor estimates and the stocks' risk/reward is "meaningfully skewed to the upside."
-- Scotiabank started coverage of Waste Connections (WCN) with a Sector Perform rating and
$196 price target as the firm resumed coverage on five leading North American environmental services companies. While the firm has a positive thesis on the sector, it is "also mindful of some key risks," including the potential for compression in valuation multiples given they are rich in a historical context, the analyst tells investors.
-- Piper Sandler assumed coverage of Peoples Bancorp (PEBO) with an Overweight rating and
$39 price target. Peoples Bancorp's high-quality deposit base, solid organic loan growth opportunities, coupled with likely core net interest margin stability in 2025, above average core fee income growth and well-controlled costs with its peer-leading tech stack, should drive superior operating leverage over the near-term and potential EPS upside, the analyst tells investors in a research note.
-- Janney Montgomery Scott initiated coverage of Cameco (CCJ) with a Buy rating and
$60 fair value estimate. The firm recommends buying shares in the global nuclear fuel and services company as it thinks Cameco is well positioned to generate strong EBITDA and free cash flow.
